Product Description
Dolutegravir Lamivudine and Tenofovir Disoproxil Fumarate Tablets are formulated with a precise combination of Dolutegravir 50 mg, Lamivudine 300 mg, and Tenofovir Disoproxil Fumarate 300 mg, ensuring optimal efficacy for relevant therapeutic applications. These medicine-grade tablets are designed for oral administration and packaged in boxes containing 30 tablets, suitable for convenient use and distribution. To retain their quality and effectiveness, the tablets should be stored at room temperature. As an exporter, supplier, and trader, this product offers reliable performance and adheres to stringent pharmaceutical standards. Developed to address specific medical needs, these tablets combine three active ingredients that work synergistically to deliver effective results.
FAQs of Dolutegravir Lamivudiine And Tenofovir Disoproxol Fumarate Tablets:
Q: What is the composition of these tablets?
A: Each tablet contains Dolutegravir 50 mg, Lamivudine 300 mg, and Tenofovir Disoproxil Fumarate 300 mg.
Q: How are the tablets packaged?
A: The tablets are packaged in boxes, with each box containing 30 tablets.
Q: What is the recommended storage condition for these tablets?
A: The tablets should be stored at room temperature to preserve their quality and effectiveness.
Q: What is the dosage form of the product?
A: The product is available in tablet form, designed for oral administration.
Q: Are these tablets medicine grade?
A: Yes, these tablets are medicine grade and meet pharmaceutical standards.